Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | HealthTech (& Fitness) • Medical Devices (& Hospital Services) |
Investing | United States |
Bourne Partners Strategic Capital is a venture capital fund headquartered at 23rd Floor 20 Fenchurch Street, London, EC3M 3BY, United Kingdom. They are deeply immersed in the HealthTech (& Fitness) and Medical Devices (& Hospital Services) industries, and they bring expertise in equity investments. Their investment focus is to provide investors with diversified exposure to early-stage technology companies that show high potential for growth and innovation, particularly in the verticals of software-centric businesses within the realms of Augmented Reality/Virtual Reality (AR/VR), Internet of Things (IoT), and Financial Technologies (FinTech). Working through a collaboration with Suir Valley Ventures and Shard Capital, Bourne Partners Strategic Capital leverages not only its expertise but also ties in with a wide-ranging innovation network and an entrepreneurial broking and asset management house to optimize opportunities in these rapidly evolving sectors. They offer direct access to a broad start-up community, including Silicon Valley, serving as a gateway to global financial markets. Their hands-on approach means they can provide immediate support to seed companies to help them accelerate growth. They are committed to backing companies through various stages of their lifecycle, from providing additional financing to facilitate scaling operations to assistance with IPOs and beyond, integrating corporate broking and investor relations functions. The fund seeks to invest in areas forecasted to experience significant growth within the next few years, with a notable emphasis on AR/VR, which is projected to reach a market size of $108 billion by 2020. Bourne Partners Strategic Capital aims to co-invest with leading VC entities like Enterprise Ireland, one of Europe's largest VCs, by funneling the first 5 million of net proceeds raised from their First Issue into Suir Valley Ventures Fund, a sub-fund of Suir Valley Funds ICAV, and potentially increasing positions in companies where investments are already made. As part of its investment rationale, the fund emphasizes the need for investors to gain access to early-stage technological advancements in their targeted sectors. Bourne Partners Strategic Capital considers investors—who may find it challenging, risky, and resource-intensive to independently build such a portfolio—would benefit from their offerings, including institutional, professionally-advised private investors, and financially knowledgeable private investors capable of evaluating the risks and appreciating the prospects of this investment niche.